摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(3-(1H-1,2,4-triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4-ethyl-benzenesulfonamide

中文名称
——
中文别名
——
英文名称
N-(3-(1H-1,2,4-triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4-ethyl-benzenesulfonamide
英文别名
4-ethyl-N-[4-hydroxy-3-(1H-1,2,4-triazol-5-ylsulfanyl)naphthalen-1-yl]benzenesulfonamide
N-(3-(1H-1,2,4-triazol-3-ylthio)-4-hydroxynaphthalen-1-yl)-4-ethyl-benzenesulfonamide化学式
CAS
——
化学式
C20H18N4O3S2
mdl
——
分子量
426.5
InChiKey
QDGHREVQMWQVBQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    29
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    142
  • 氢给体数:
    3
  • 氢受体数:
    7

文献信息

  • Methods for inhibiting fascin
    申请人:Novita Pharmaceuticals, Inc.
    公开号:US10208043B2
    公开(公告)日:2019-02-19
    Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
    提供了用于治疗有需要的受试者中由 fascin 活性介导的病症或紊乱的组合物和方法,该方法包括向受试者施用治疗有效量的至少一种式 I-a 至 I-n、II、II-a、II-b 或 III 中任何一种的化合物或其药学上可接受的盐。
  • METHODS FOR INHIBITING FASCIN
    申请人:Cornell University
    公开号:EP2888010A2
    公开(公告)日:2015-07-01
  • FASCIN BINDING COMPOUNDS FOR SPINOGENESIS
    申请人:SPINOGENIX, INC.
    公开号:US20210330646A1
    公开(公告)日:2021-10-28
    In some embodiments, a method of promoting spinogenesis in a patient is provided, comprising administering to a patient in need thereof a therapeutically effective amount of a compound which binds to fascin at least at binding site 2 or binding site 3.
  • [EN] METHODS FOR INHIBITING FASCIN<br/>[FR] MÉTHODES D'INHIBITION DE LA FASCINE
    申请人:UNIV CORNELL
    公开号:WO2014031732A2
    公开(公告)日:2014-02-27
    Provided are compositions and methods for treating a condition or disorder mediated by fascin activity in a subject in need thereof which method comprises administering to the subject a therapeutically effective amount of at least one compound of any one of Formula I-a to I-n, II, II-a, II-b or III or a pharmaceutically acceptable salt thereof.
查看更多